Last reviewed · How we verify

Virtual Incentive Treatment for Alcohol (VITA)

NCT06265506 NA RECRUITING

The overall objective of this program of research is to utilize phosphatidylethanol (PEth), a blood-based biomarker that can detect alcohol use for up to 28 days to deliver a feasible telehealth-based 26-week CM intervention. This study will test a telehealth PEth-based CM model in a sample of adults with AUD (n=200), recruited via online platforms by randomizing individuals to six months of 1) an online cognitive behavioral therapy for AUD (CBT4CBT) and telehealth PEth-based CM (CM condition) or 2) CBT4CBT and reinforcers for submitting blood samples (no abstinence required) (control condition). Investigators will assess group differences in PEth-defined abstinence and regular excessive drinking (PEth \>= 200 ng/mL), and alcohol-related harms (e.g., smoking, drug use). This study will address important gaps in CM research by assessing outcomes during a 12-month follow-up, which is much longer than most previous CM studies; using a conceptual model to identify predictors of post-treatment abstinence. Investigators will conduct an economic analysis to place the cost of this model in the context of downstream CM-associated cost-offsets and improvements in personal and public health.

Details

Lead sponsorWashington State University
PhaseNA
StatusRECRUITING
Enrolment200
Start dateTue Jun 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionTue Apr 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

United States